SLC7A11 and neoplasm: Interestingly, recent evidence demonstrated that under ICB treatment, CD8+ T cells-derived IFN-γ downregulates the two key subunits (SLC7A11, SLC3A2) of the glutamate-cystine antiporter xCT, thereby promoting tumor ferroptosis 93.